Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19 (HoCoPsy)
Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context
The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable.
On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.
By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.
It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.
This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
The main objective is to notice if we can observe a increase in the number of unvonluntary commitment the month after the announce of the confinement in the psychiatric hospital La Colombière, CHU Montpellier, France.
Secondary objectives :
- Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients
- Assess the lengh of the hospitalization
- Assess the number of patients hospitalized without psychiatric antecedent
- Assess the number of treatment interruptions in the recent history before hospitalization
- Asses the number of patients living alone
- Asses the number of patients using drugs
It is expected to highlight :
- An increase of the number of unvontuntary commitment
- If one or several mental disorders were more at risk of requiring an unvonluntary commitment
- An increased lengh of hospitalization
- An increased number of unvonluntary commitment of patients without psychiatric antecedent
- An increased number of treatment interruptions
- A link between hospitalization and living alone
- A link between hospitalization and using drugs
The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.
The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
-
Montpellier, Frankrijk, 34295
- University Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion criteria:
- Unvonluntary commitment in psychiatric hospital La Colombière, CHU Montpellier, from march 12th to april 19th (2019 and 2020).
Exclusion criteria:
- refusal to participate
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Unvonluntary commitment from March 12th to April 09th 2019
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2019
|
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
|
|
Unvonluntary commitment from March 12th to April 09th 2020
Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2020
|
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Number of hospitalized patients
Tijdsspanne: 1 months
|
Number of hospitalized patients From March 12th to April 09th
|
1 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Cause of hospitalization
Tijdsspanne: 1 months
|
Primary psychiatric diagnostic From March 12th to April 09th
|
1 months
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Lengh of hospitalization
Tijdsspanne: 1 months
|
Patients without psychiatric antecedent (number) From March 12th to April 09th
|
1 months
|
|
Treatment interruption
Tijdsspanne: 1 months
|
Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th
|
1 months
|
|
Number of hospitalized patients living alone
Tijdsspanne: 1 months
|
Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th
|
1 months
|
|
Use of drugs
Tijdsspanne: 1 months
|
Number of patients using drugs From March 12th to April 09th
|
1 months
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Emilie OLIE, MD PhD, University Hospital, Montpellier
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- RECHMPL20_0320
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .